Prognostic Value of Skull Base Foramen Invasion Subclassification in T Category Modification and Induction Chemotherapy Management for Nasopharyngeal Carcinoma: Post‐Hoc Analysis of a Dual‐Center Retrospective Cohort Study

Abstract Skull base foramen invasion (SBFI) indicates poor prognosis in nasopharyngeal carcinoma (NPC). However, only a few studies systematically assessed the role of SBFIin staging and treatment of NPC. To investigate the prognostic value of SBFI in NPC, a total of 1,752 patients with nonmetastati...

Full description

Saved in:
Bibliographic Details
Main Authors: Siyu Zhu, Shuqi Li, Di Cao, Chao Luo, Zhiying Liang, Shaobo Liang, Guoyi Zhang, Qin Zhao, Guangying Ruan, Lizhi Liu, Gui Fu, Haojiang Li
Format: Article
Language:English
Published: Wiley 2025-01-01
Series:Advanced Science
Subjects:
Online Access:https://doi.org/10.1002/advs.202408182
Tags: Add Tag
No Tags, Be the first to tag this record!
_version_ 1832582744604934144
author Siyu Zhu
Shuqi Li
Di Cao
Chao Luo
Zhiying Liang
Shaobo Liang
Guoyi Zhang
Qin Zhao
Guangying Ruan
Lizhi Liu
Gui Fu
Haojiang Li
author_facet Siyu Zhu
Shuqi Li
Di Cao
Chao Luo
Zhiying Liang
Shaobo Liang
Guoyi Zhang
Qin Zhao
Guangying Ruan
Lizhi Liu
Gui Fu
Haojiang Li
author_sort Siyu Zhu
collection DOAJ
description Abstract Skull base foramen invasion (SBFI) indicates poor prognosis in nasopharyngeal carcinoma (NPC). However, only a few studies systematically assessed the role of SBFIin staging and treatment of NPC. To investigate the prognostic value of SBFI in NPC, a total of 1,752 patients with nonmetastatic NPC from two hospitals (1,320 and 432) between January 2010 and March 2014 are enrolled. The primary endpoint is overall survival (OS). Heatmap/cluster and network analyses are used to provide subclassification indication. Univariate and multivariate analyses with Kaplan–Meier method are performed to compare survival outcomes. SBFIs are classified into slight (only foramen lacerum and/or pterygopalatine fossa invasion) and severe (other SBFIs). The severe SBFI is an unfavorable prognosticator for OS in both the entire cohort and the T3 group. OS is similar between T3 with severe SBFI and T4 patients. Reclassifying T3 with severe SBFI as the T4 category yields an improved T category discrimination. Additionally, patients in the severe SBFI group gain significant survival benefits from induction chemotherapy ((IC). Therefore, T3 NPC with severe SBFI is an independent negative predictor for OS and is classified into the T4 category. T category adjustment enables better prognostic stratification. Severe SBFI benefits from IC in long‐term OS.
format Article
id doaj-art-4a62d502742144daa151f9ad293eb7c4
institution Kabale University
issn 2198-3844
language English
publishDate 2025-01-01
publisher Wiley
record_format Article
series Advanced Science
spelling doaj-art-4a62d502742144daa151f9ad293eb7c42025-01-29T09:50:19ZengWileyAdvanced Science2198-38442025-01-01124n/an/a10.1002/advs.202408182Prognostic Value of Skull Base Foramen Invasion Subclassification in T Category Modification and Induction Chemotherapy Management for Nasopharyngeal Carcinoma: Post‐Hoc Analysis of a Dual‐Center Retrospective Cohort StudySiyu Zhu0Shuqi Li1Di Cao2Chao Luo3Zhiying Liang4Shaobo Liang5Guoyi Zhang6Qin Zhao7Guangying Ruan8Lizhi Liu9Gui Fu10Haojiang Li11Department of Radiology State Key Laboratory of Oncology in South China Guangdong Key Laboratory of Nasopharyngeal Carcinoma Diagnosis and Therapy Guangdong Provincial Clinical Research Center for Cancer Sun Yat‐sen University Cancer Center Guangzhou 510060 P. R. ChinaDepartment of Radiology State Key Laboratory of Oncology in South China Guangdong Key Laboratory of Nasopharyngeal Carcinoma Diagnosis and Therapy Guangdong Provincial Clinical Research Center for Cancer Sun Yat‐sen University Cancer Center Guangzhou 510060 P. R. ChinaDepartment of Radiology State Key Laboratory of Oncology in South China Guangdong Key Laboratory of Nasopharyngeal Carcinoma Diagnosis and Therapy Guangdong Provincial Clinical Research Center for Cancer Sun Yat‐sen University Cancer Center Guangzhou 510060 P. R. ChinaDepartment of Radiology State Key Laboratory of Oncology in South China Guangdong Key Laboratory of Nasopharyngeal Carcinoma Diagnosis and Therapy Guangdong Provincial Clinical Research Center for Cancer Sun Yat‐sen University Cancer Center Guangzhou 510060 P. R. ChinaDepartment of Radiology State Key Laboratory of Oncology in South China Guangdong Key Laboratory of Nasopharyngeal Carcinoma Diagnosis and Therapy Guangdong Provincial Clinical Research Center for Cancer Sun Yat‐sen University Cancer Center Guangzhou 510060 P. R. ChinaDepartment of Radiation Oncology Foshan Academy of Medical Sciences Sun Yat‐Sen University Foshan Hospital and The First People's Hospital of Foshan Foshan 528000 P. R. ChinaDepartment of Radiation Oncology Foshan Academy of Medical Sciences Sun Yat‐Sen University Foshan Hospital and The First People's Hospital of Foshan Foshan 528000 P. R. ChinaDepartment of Radiology State Key Laboratory of Oncology in South China Guangdong Key Laboratory of Nasopharyngeal Carcinoma Diagnosis and Therapy Guangdong Provincial Clinical Research Center for Cancer Sun Yat‐sen University Cancer Center Guangzhou 510060 P. R. ChinaDepartment of Radiology State Key Laboratory of Oncology in South China Guangdong Key Laboratory of Nasopharyngeal Carcinoma Diagnosis and Therapy Guangdong Provincial Clinical Research Center for Cancer Sun Yat‐sen University Cancer Center Guangzhou 510060 P. R. ChinaDepartment of Radiology State Key Laboratory of Oncology in South China Guangdong Key Laboratory of Nasopharyngeal Carcinoma Diagnosis and Therapy Guangdong Provincial Clinical Research Center for Cancer Sun Yat‐sen University Cancer Center Guangzhou 510060 P. R. ChinaDepartment of Radiology State Key Laboratory of Oncology in South China Guangdong Key Laboratory of Nasopharyngeal Carcinoma Diagnosis and Therapy Guangdong Provincial Clinical Research Center for Cancer Sun Yat‐sen University Cancer Center Guangzhou 510060 P. R. ChinaDepartment of Radiology State Key Laboratory of Oncology in South China Guangdong Key Laboratory of Nasopharyngeal Carcinoma Diagnosis and Therapy Guangdong Provincial Clinical Research Center for Cancer Sun Yat‐sen University Cancer Center Guangzhou 510060 P. R. ChinaAbstract Skull base foramen invasion (SBFI) indicates poor prognosis in nasopharyngeal carcinoma (NPC). However, only a few studies systematically assessed the role of SBFIin staging and treatment of NPC. To investigate the prognostic value of SBFI in NPC, a total of 1,752 patients with nonmetastatic NPC from two hospitals (1,320 and 432) between January 2010 and March 2014 are enrolled. The primary endpoint is overall survival (OS). Heatmap/cluster and network analyses are used to provide subclassification indication. Univariate and multivariate analyses with Kaplan–Meier method are performed to compare survival outcomes. SBFIs are classified into slight (only foramen lacerum and/or pterygopalatine fossa invasion) and severe (other SBFIs). The severe SBFI is an unfavorable prognosticator for OS in both the entire cohort and the T3 group. OS is similar between T3 with severe SBFI and T4 patients. Reclassifying T3 with severe SBFI as the T4 category yields an improved T category discrimination. Additionally, patients in the severe SBFI group gain significant survival benefits from induction chemotherapy ((IC). Therefore, T3 NPC with severe SBFI is an independent negative predictor for OS and is classified into the T4 category. T category adjustment enables better prognostic stratification. Severe SBFI benefits from IC in long‐term OS.https://doi.org/10.1002/advs.202408182category modificationnasopharyngeal carcinomaskull base foramen invasiontreatment management
spellingShingle Siyu Zhu
Shuqi Li
Di Cao
Chao Luo
Zhiying Liang
Shaobo Liang
Guoyi Zhang
Qin Zhao
Guangying Ruan
Lizhi Liu
Gui Fu
Haojiang Li
Prognostic Value of Skull Base Foramen Invasion Subclassification in T Category Modification and Induction Chemotherapy Management for Nasopharyngeal Carcinoma: Post‐Hoc Analysis of a Dual‐Center Retrospective Cohort Study
Advanced Science
category modification
nasopharyngeal carcinoma
skull base foramen invasion
treatment management
title Prognostic Value of Skull Base Foramen Invasion Subclassification in T Category Modification and Induction Chemotherapy Management for Nasopharyngeal Carcinoma: Post‐Hoc Analysis of a Dual‐Center Retrospective Cohort Study
title_full Prognostic Value of Skull Base Foramen Invasion Subclassification in T Category Modification and Induction Chemotherapy Management for Nasopharyngeal Carcinoma: Post‐Hoc Analysis of a Dual‐Center Retrospective Cohort Study
title_fullStr Prognostic Value of Skull Base Foramen Invasion Subclassification in T Category Modification and Induction Chemotherapy Management for Nasopharyngeal Carcinoma: Post‐Hoc Analysis of a Dual‐Center Retrospective Cohort Study
title_full_unstemmed Prognostic Value of Skull Base Foramen Invasion Subclassification in T Category Modification and Induction Chemotherapy Management for Nasopharyngeal Carcinoma: Post‐Hoc Analysis of a Dual‐Center Retrospective Cohort Study
title_short Prognostic Value of Skull Base Foramen Invasion Subclassification in T Category Modification and Induction Chemotherapy Management for Nasopharyngeal Carcinoma: Post‐Hoc Analysis of a Dual‐Center Retrospective Cohort Study
title_sort prognostic value of skull base foramen invasion subclassification in t category modification and induction chemotherapy management for nasopharyngeal carcinoma post hoc analysis of a dual center retrospective cohort study
topic category modification
nasopharyngeal carcinoma
skull base foramen invasion
treatment management
url https://doi.org/10.1002/advs.202408182
work_keys_str_mv AT siyuzhu prognosticvalueofskullbaseforameninvasionsubclassificationintcategorymodificationandinductionchemotherapymanagementfornasopharyngealcarcinomaposthocanalysisofadualcenterretrospectivecohortstudy
AT shuqili prognosticvalueofskullbaseforameninvasionsubclassificationintcategorymodificationandinductionchemotherapymanagementfornasopharyngealcarcinomaposthocanalysisofadualcenterretrospectivecohortstudy
AT dicao prognosticvalueofskullbaseforameninvasionsubclassificationintcategorymodificationandinductionchemotherapymanagementfornasopharyngealcarcinomaposthocanalysisofadualcenterretrospectivecohortstudy
AT chaoluo prognosticvalueofskullbaseforameninvasionsubclassificationintcategorymodificationandinductionchemotherapymanagementfornasopharyngealcarcinomaposthocanalysisofadualcenterretrospectivecohortstudy
AT zhiyingliang prognosticvalueofskullbaseforameninvasionsubclassificationintcategorymodificationandinductionchemotherapymanagementfornasopharyngealcarcinomaposthocanalysisofadualcenterretrospectivecohortstudy
AT shaoboliang prognosticvalueofskullbaseforameninvasionsubclassificationintcategorymodificationandinductionchemotherapymanagementfornasopharyngealcarcinomaposthocanalysisofadualcenterretrospectivecohortstudy
AT guoyizhang prognosticvalueofskullbaseforameninvasionsubclassificationintcategorymodificationandinductionchemotherapymanagementfornasopharyngealcarcinomaposthocanalysisofadualcenterretrospectivecohortstudy
AT qinzhao prognosticvalueofskullbaseforameninvasionsubclassificationintcategorymodificationandinductionchemotherapymanagementfornasopharyngealcarcinomaposthocanalysisofadualcenterretrospectivecohortstudy
AT guangyingruan prognosticvalueofskullbaseforameninvasionsubclassificationintcategorymodificationandinductionchemotherapymanagementfornasopharyngealcarcinomaposthocanalysisofadualcenterretrospectivecohortstudy
AT lizhiliu prognosticvalueofskullbaseforameninvasionsubclassificationintcategorymodificationandinductionchemotherapymanagementfornasopharyngealcarcinomaposthocanalysisofadualcenterretrospectivecohortstudy
AT guifu prognosticvalueofskullbaseforameninvasionsubclassificationintcategorymodificationandinductionchemotherapymanagementfornasopharyngealcarcinomaposthocanalysisofadualcenterretrospectivecohortstudy
AT haojiangli prognosticvalueofskullbaseforameninvasionsubclassificationintcategorymodificationandinductionchemotherapymanagementfornasopharyngealcarcinomaposthocanalysisofadualcenterretrospectivecohortstudy